MedPath

The Single Arm Clinical Study To Evaluate The Effect Of Hingvadi Gutika In Udavarta Yonivyapada

Phase 2
Not yet recruiting
Conditions
Primary dysmenorrhea. Ayurveda Condition: YONIROGAH/YONI-VYAPADAH,
Registration Number
CTRI/2024/01/061928
Lead Sponsor
SANE GURUJI AROGYA KENDRA
Brief Summary

THIS IS AN OPEN LABEL SINGLE ARM  CLINICAL STUDY TO EVALUATE THE EFFECT OF HINGVADI GUTIKA IN UDAVARTA YONIVYAPADA.

THE PRIMARY OBJECTIVE IS TO STUDY THE EFFECT OF HINGVADI GUTIKA IN UDAVARTA YONIVYAPADA FOR A DURATION OF 60 DAYS.

REGULAR ASSESSMENT OF SIGNS AND SYMPTOMS WILL BE DONE. OBSERVATION WILL BE DRAWN FROM THE OUTCOME OF PATIENT.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
30
Inclusion Criteria
  • Patient suffering from udavarta Yoni Vyapada 2.
  • Married or unmarried patient of age group 20 to30 yrs 3.
  • Patient having pain during Menstruation 4.
  • Patient having painful menses as compared to previous menses 5.
  • Patient ready for clinical trial.
Exclusion Criteria
  • Hypothyroidism, HIV, HbsAg, VDRL, prolactaemia, tuberculosis,utrine fibroid,complex ovarian cyst, dermoid cyst, tubo-ovarian mass, cervical polyp or growth.
  • 5 Patients suffering from uterine synechiae, endometriosis or malignancy.
  • 6 Pregnancy lactating and post natal female.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The effect of Hingvadi Gutika 250 mg BD orally in Udavarta Yonivyapada18 months
Secondary Outcome Measures
NameTimeMethod
Literature study of Udavarta Yonivyapada.Preparation of Hingvadi Gutika

Trial Locations

Locations (1)

Sane Guruji Arogya Kendra

🇮🇳

Pune, MAHARASHTRA, India

Sane Guruji Arogya Kendra
🇮🇳Pune, MAHARASHTRA, India
Dr Prachi Sanjog Pardeshi
Principal investigator
8999822065
pardeshiprachie30@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.